Neuphoria Therapeutics Inc (NEUP)

$4.79 +0.04 (0.84%)
Market Cap 11.55M
Revenue (ttm) 15.65M
Net Income (ttm) -370,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2.36%
Debt to Equity Ratio 0.00
Volume 333,000
Avg Vol 1,966,868
Day's Range N/A - N/A
Shares Out 2.36M
Stochastic %K 66%
Beta 0.51
Analysts Strong Sell
Price Target $20.50

Company Profile

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 439 5551
Address:
100 Summit Drive, Burlington, United States
I_am_retail_investor
I_am_retail_investor Nov. 14 at 7:07 PM
$NEUP - big middle finger to the retail
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 1:34 PM
$NEUP AI Overview Merck is acquiring Cidara Therapeutics in a deal valued at approximately $9.2 billion. The acquisition, announced today, is for Cidara Therapeutics, a company developing a long-acting antiviral for influenza prevention.
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 1:29 PM
$NEUP An extreme amount of warrant dilution but this stock is way under valued IMO - NFA On a side note, did anyone notice who MERCK bought out for $9B today❓
0 · Reply
DT1987
DT1987 Nov. 14 at 12:51 PM
$NEUP ER silently released. that explains the gap down
1 · Reply
danial88
danial88 Nov. 14 at 12:44 PM
$NEUP wtf
0 · Reply
DT1987
DT1987 Nov. 14 at 12:43 PM
$NEUP wtf
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 12:33 AM
$NEUP WOW. Look at what showed up today. Remember these are from previous quarter results So it does NOT mean LYNX1 sold their shares today 👇👇👇👇👇👇👇👇
0 · Reply
DT1987
DT1987 Nov. 13 at 11:35 PM
$NEUP not hating today's candle, actually. could see a green one tom, close near $5 🤞🏽
0 · Reply
Rufusbird
Rufusbird Nov. 13 at 9:22 PM
$NEUP I had the same note in my calendar but can't find the quote anywhere. Can you give us a link to it? Thanks in advance.
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 13 at 5:01 PM
$NEUP OK, Buyout offer cancelled, now does LYNX1 make a higher offer? "We believe that this proposal represents a highly beneficial outcome for the Company and its stockholders and are excited by the potential benefits that the Acquisition would yield for all stakeholders. We appreciate your consideration of this proposal and look forward to hearing from you as soon as possible but no later than 12:00 p.m. (noon), New York time, on November 13, 2025."
0 · Reply
Latest News on NEUP
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Nov 11, 2025, 7:00 AM EST - 3 days ago

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

Oct 27, 2025, 4:29 PM EDT - 18 days ago

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Oct 21, 2025, 8:16 AM EDT - 24 days ago

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

CTXR PCAR

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Oct 20, 2025, 4:15 PM EDT - 25 days ago

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Sep 29, 2025, 4:54 PM EDT - 6 weeks ago

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

Sep 4, 2025, 7:00 AM EDT - 2 months ago

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 28, 2025, 4:05 PM EDT - 2 months ago

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

May 27, 2025, 4:10 PM EDT - 6 months ago

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

Neuphoria Provides First Quarter 2025 Business Updates

May 20, 2025, 4:22 PM EDT - 6 months ago

Neuphoria Provides First Quarter 2025 Business Updates

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Apr 15, 2025, 8:00 AM EDT - 7 months ago

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Mar 3, 2025, 7:30 AM EST - 9 months ago

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Feb 12, 2025, 7:00 AM EST - 9 months ago

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

Dec 23, 2024, 4:49 PM EST - 11 months ago

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

I_am_retail_investor
I_am_retail_investor Nov. 14 at 7:07 PM
$NEUP - big middle finger to the retail
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 1:34 PM
$NEUP AI Overview Merck is acquiring Cidara Therapeutics in a deal valued at approximately $9.2 billion. The acquisition, announced today, is for Cidara Therapeutics, a company developing a long-acting antiviral for influenza prevention.
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 1:29 PM
$NEUP An extreme amount of warrant dilution but this stock is way under valued IMO - NFA On a side note, did anyone notice who MERCK bought out for $9B today❓
0 · Reply
DT1987
DT1987 Nov. 14 at 12:51 PM
$NEUP ER silently released. that explains the gap down
1 · Reply
danial88
danial88 Nov. 14 at 12:44 PM
$NEUP wtf
0 · Reply
DT1987
DT1987 Nov. 14 at 12:43 PM
$NEUP wtf
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 14 at 12:33 AM
$NEUP WOW. Look at what showed up today. Remember these are from previous quarter results So it does NOT mean LYNX1 sold their shares today 👇👇👇👇👇👇👇👇
0 · Reply
DT1987
DT1987 Nov. 13 at 11:35 PM
$NEUP not hating today's candle, actually. could see a green one tom, close near $5 🤞🏽
0 · Reply
Rufusbird
Rufusbird Nov. 13 at 9:22 PM
$NEUP I had the same note in my calendar but can't find the quote anywhere. Can you give us a link to it? Thanks in advance.
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 13 at 5:01 PM
$NEUP OK, Buyout offer cancelled, now does LYNX1 make a higher offer? "We believe that this proposal represents a highly beneficial outcome for the Company and its stockholders and are excited by the potential benefits that the Acquisition would yield for all stakeholders. We appreciate your consideration of this proposal and look forward to hearing from you as soon as possible but no later than 12:00 p.m. (noon), New York time, on November 13, 2025."
0 · Reply
DT1987
DT1987 Nov. 13 at 4:28 PM
$NEUP welp. looks like itll test $4.50 tom. MMs dont want the SP going up
0 · Reply
stabbed
stabbed Nov. 13 at 4:13 PM
$NEUP - someone willing to buy for $5.20 but the stock is dumped to $4.66 How retarded is that?!?
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 13 at 3:01 PM
$NEUP Or LYNX1 comes out with a higher offer and it runs to $5.50+ IMO - NFA
0 · Reply
DT1987
DT1987 Nov. 13 at 2:21 PM
$NEUP no catalyst, no PM movement above $5, guessing another red candle today
0 · Reply
Moneyboy231
Moneyboy231 Nov. 13 at 2:13 PM
$BCTX $IXHL $NEUP $QCLS are you bearish on IXHL?
3 · Reply
IldijanaMM
IldijanaMM Nov. 13 at 2:12 PM
$BCTX $IXHL $NEUP $QCLS Well look who’s back after been locked out 😄 for spamming Welcome back Stocktwits biggest pumper and worst investor!
2 · Reply
JJBurch
JJBurch Nov. 13 at 12:55 PM
$IXHL We are so close now! This is my current #1 HOLDING!! News at ANY moment sends this back above $1 - Partner - Buyback - Data $QCLS patience will pay; we know this! #NoTrollZone ;) $BCTX $NEUP holding
0 · Reply
stabbed
stabbed Nov. 13 at 2:06 AM
$NEUP
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Nov. 13 at 1:08 AM
$NEUP Is that MERCK I see on the Institutional Ownership. They may have to get more so Lynx can't perform a buyout. 👇👇👇👇👇👇👇👇
0 · Reply
Mitch___Picks
Mitch___Picks Nov. 12 at 3:37 PM
$NEUP new swing idea in the mid 4s for potential 100%+ swing trade. Liking these type of charts in November for runners.
0 · Reply
QuietTrader
QuietTrader Nov. 12 at 2:31 PM
$HP $CMG $NEUP $CRSP $PLTR think some of you are catching onto the fact that I like to buy stocks when they’re undesirable but have the potential of becoming undeniable.
0 · Reply
mikesterz7
mikesterz7 Nov. 11 at 10:49 PM
$PSIL $NEUP Neuphoria also added that it received an unsolicited non-binding indication of interest from Lynx1 Master Fund LP earlier this week to acquire all of the outstanding shares of Neuphoria that it does not already own for $5.20 per share in cash.
0 · Reply